PATENT CLAIM ANALYSIS

Application Number: 16287771
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["549", "408000"]

Abstract:
The present invention provides compounds that modulate the interaction of TCR with Nck, compositions thereof, and methods of treatment using the same.

Claim (Index 4):
The compound according to  claim 3 , wherein L 1  is a covalent bond, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 99.0
- Lexical Diversity: 1.13636
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11046664', '13873591', '13560131', '12670989', '13308612']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7614451924108003
- 35 USC 102 Novelty (BERT): 0.4901831328112515
- Combined Prediction Score: 0.7343189864508455
- Mean Citation Score: 260.24751000000003
- Max Citation Score: 261.19708
- Similarity Product: 223.1182213607264

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test